Prothena Corporation PLC PRTA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:09 PM EDT
30.06quote price arrow down-0.22 (-0.73%)
Volume
2,696
Close
30.28quote price arrow down-2.73 (-8.27%)
Volume
332,902
52 week range
21.06 - 79.75
Loading...
  • Open33.19
  • Day High33.19
  • Day Low29.29
  • Prev Close33.01
  • 52 Week High79.75
  • 52 Week High Date09/27/21
  • 52 Week Low21.06
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap1.417B
  • Shares Out46.81M
  • 10 Day Average Volume0.24M
  • Dividend-
  • Dividend Yield-
  • Beta1.30
  • YTD % Change-38.7

KEY STATS

  • Open33.19
  • Day High33.19
  • Day Low29.29
  • Prev Close33.01
  • 52 Week High79.75
  • 52 Week High Date09/27/21
  • 52 Week Low21.06
  • 52 Week Low Date06/16/22
  • Market Cap1.417B
  • Shares Out46.81M
  • 10 Day Average Volume0.24M
  • Dividend-
  • Dividend Yield-
  • Beta1.30
  • YTD % Change-38.7

RATIOS/PROFITABILITY

  • EPS (TTM)-0.23
  • P/E (TTM)-128.96
  • Fwd P/E (NTM)-9.10
  • EBITDA (TTM)67.171M
  • ROE (TTM)20.02%
  • Revenue (TTM)201.57M
  • Gross Margin (TTM)-
  • Net Margin (TTM)33.45%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/04/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Prothena Corporation PLC

There is no recent news for this security.

Profile

MORE
Prothena Corporation plc is a late-stage clinical company engaged in the protein dysregulation and a pipeline of novel investigational therapies for rare peripheral amyloid and neurodegenerative diseases. The Company is advancing a pipeline of therapeutic candidates for a range of indications and novel targets to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins. The Company is also advancing several discovery and...
Lars Ekman M.D., Ph.D.
Independent Chairman of the Board
Gene Kinney Ph.D.
President, Chief Executive Officer, Director
Brandon Smith
Chief Operating Officer
Tran Nguyen
Chief Financial Officer, Chief Strategy Officer
Karin Walker CPA
Chief Accounting Officer
Address
77 Sir John Rogersons Quay
Block C, Grand Canal Docklands
Dublin
D02 T804
Ireland

Top Peers

SYMBOLLASTCHG%CHG
VCEL
Vericel Corp
27.43-2.41-8.08%
ADPT
Adaptive Biotechnologies Corp
11.21-0.48-4.11%
PACB
Pacific Biosciences of California Inc
6.66-0.24-3.48%
SNDX
Syndax Pharmaceuticals Inc
23.99-0.29-1.19%
ENTA
Enanta Pharmaceuticals Inc
68.27-3.00-4.21%